keyword
https://read.qxmd.com/read/38654193/fructose-malabsorption-and-fructan-malabsorption-are-associated-in-patients-with-irritable-bowel-syndrome
#21
JOURNAL ARTICLE
Twan Sia, Riki O Tanaka, Albert Mousad, Aditya P Narayan, Kristen Si, Leeon Bacchus, Hind Ouerghi, Aashka Patel, Arnav Patel, Evan Cunningham, Taylor Epstein, Jerry Fu, Stanley Liu, Raisa Khuda, Paige McDonald, Shibani Mallik, Joanna McNulty, Michelle Pan, John Leung
BACKGROUND: Food malabsorption and intolerance is implicated in gastrointestinal symptoms among patients with irritable bowel syndrome (IBS). Key triggers include fructose and fructan. Prior studies examined fructose and fructan malabsorption separately in IBS patients. None have concurrently assessed both within the same patient group. We aimed to investigate the association between fructose and fructan malabsorption in the same patients with IBS using hydrogen breath testing (HBT). METHODS: We retrospectively identified patients with IBS who underwent fructose and fructan HBTs and abstracted their results from the electronic medical record...
April 24, 2024: BMC Gastroenterology
https://read.qxmd.com/read/38653951/correction-to-association-between-bowel-wall-thickening-and-long-term-outcomes-in-decompensated-liver-cirrhosis
#22
Xueying Wang, Min Ding, Weiwei Wang, Xiaojie Zheng, Cyriac Abby Philips, Nahum Méndez-Sánchez, Hongxu Jin, Xingshun Qi
No abstract text is available yet for this article.
April 23, 2024: Advances in Therapy
https://read.qxmd.com/read/38653907/contributions-of-synthetic-chemicals-to-autoimmune-disease-development-and-occurrence
#23
REVIEW
Noelle N Kosarek, Emma V Preston
PURPOSE OF REVIEW: Exposure to many synthetic chemicals has been linked to a variety of adverse human health effects, including autoimmune diseases. In this scoping review, we summarize recent evidence detailing the effects of synthetic environmental chemicals on autoimmune diseases and highlight current research gaps and recommendations for future studies. RECENT FINDINGS: We identified 68 recent publications related to environmental chemical exposures and autoimmune diseases...
April 24, 2024: Current Environmental Health Reports
https://read.qxmd.com/read/38653808/acacia-fiber-or-probiotic-supplements-to-relieve-gastrointestinal-complaints-in-patients-with-constipation-predominant-ibs-a-4-week-randomized-double-blinded-placebo-controlled-intervention-trial
#24
JOURNAL ARTICLE
Lonneke JanssenDuijghuijsen, Maartje van den Belt, Iris Rijnaarts, Paul Vos, Damien Guillemet, Ben Witteman, Nicole de Wit
PURPOSE: To date, no adequate treatment for irritable bowel syndrome with predominant constipation complaints (IBS-C) is available. Fibers with prebiotic properties and probiotic compounds have shown promise in relieving IBS-C-related complaints. We aimed to determine the effects of a 4-week intervention with either an Acacia fiber (AF) with prebiotic properties or a probiotic Bifidobacterium Lactis (BLa80) supplement, compared to a control supplement, on stool pattern, IBS symptoms and Quality of Life (QoL), in IBS-C individuals...
April 23, 2024: European Journal of Nutrition
https://read.qxmd.com/read/38653643/post-infectious-ibs-following-clostridioides-difficile-infection-role-of-microbiota-and-implications-for-treatment
#25
REVIEW
Dana Taghaddos, Zarwa Saqib, Xaiopeng Bai, Premysl Bercik, Stephen M Collins
Up to 25% of patients recovering from antibiotic-treated Clostridioides difficile infection (CDI) develop functional symptoms reminiscent of Post-Infectious Irritable Bowel Syndrome (PI-IBS). For patients with persistent symptoms following infection, a clinical dilemma arises as to whether to provide additional antibiotic treatment or to adopt a conservative symptom-based approach. Here, we review the literature on CDI-related PI-IBS and compare the findings with PI-IBS. We review proposed mechanisms, including the role of C...
April 22, 2024: Digestive and Liver Disease
https://read.qxmd.com/read/38653572/targeting-diarrhea-predominant-irritable-bowel-syndrome-hopes-or-hypes
#26
EDITORIAL
Gabrio Bassotti
No abstract text is available yet for this article.
April 23, 2024: Expert Opinion on Investigational Drugs
https://read.qxmd.com/read/38653566/safety-of-biologics-and-small-molecules-for-inflammatory-bowel-diseases-in-organ-transplant-recipients
#27
JOURNAL ARTICLE
Ga Hee Kim, Minjun Kim, Kyuwon Kim, Jung-Bin Park, Ji Eun Baek, June Hwa Bae, Seung Wook Hong, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Sang Hyoung Park
PURPOSE: This study aimed to evaluate the safety of biologics and small molecules for the treatment of inflammatory bowel diseases (IBD) in patients receiving antirejection therapies after organ transplants. MATERIALS AND METHODS: We reviewed the medical records of patients with IBD who received organ transplants at the Asan Medical Center between January 1989 and December 2021. We compared the parameters of patients receiving biologics or small molecules to those of patients without those therapies...
May 2024: Yonsei Medical Journal
https://read.qxmd.com/read/38653495/transitional-care-in-patients-with-hirschsprung-disease-those-left-behind
#28
JOURNAL ARTICLE
David S Thompson, Joseph R Davidson, Kathryne Ford, Stavros Loukogeorgakis, Simon Eaton, Simon Blackburn, Joseph Curry
BACKGROUND: The long term effects of Hirschsprung disease are clinically variable. Improved understanding of challenges patients may face as adults can help inform transitional care management. OBJECTIVE: To explore the outcomes and transitional care experiences in adult patients with Hirschsprung. DESIGN: Cohort study. SETTING: Single center. PATIENTS: All patients treated for Hirschsprung 1977-2001 (aged >18 at time of survey July 2018-2019)...
April 23, 2024: Diseases of the Colon and Rectum
https://read.qxmd.com/read/38653494/segmental-colectomy-in-ulcerative-colitis
#29
JOURNAL ARTICLE
Sumeyye Yilmaz, Rebecca L Gunter, Arielle E Kanters, David R Rosen, Jeremy Lipman, Stefan D Holubar, Tracy L Hull, Scott R Steele
BACKGROUND: Segmental colectomy in ulcerative colitis is performed in select patients who may be at increased risk for postoperative morbidity. OBJECTIVE: To identify ulcerative colitis patients who underwent segmental colectomy and assess their postoperative and long-term outcomes. DESIGN: Retrospective case series. SETTING: A tertiary-care inflammatory bowel disease center. PATIENTS: Ulcerative colitis patients who underwent surgery between 1995 and 2022...
April 23, 2024: Diseases of the Colon and Rectum
https://read.qxmd.com/read/38652966/the-histamine-h-4-receptor-antagonist-1-5-chloro-2-3-dihydro-1-benzofuran-2-yl-methyl-4-methyl-piperazine-lins01007-prevents-the-development-of-dss-induced-colitis-in-mice
#30
JOURNAL ARTICLE
Beatriz K Lippi, Gustavo A B Fernandes, Gabriela A Azevedo, Nathani G S Negreiros, Antonio W Soares, Maristella A Landgraf, João Paulo S Fernandes, Richardt G Landgraf
Ulcerative colitis (UC) is a chronic inflammatory bowel disease with growing incidence worldwide. Our group reported the compound 5-choro-1-[(2,3-dihydro-1-benzofuran-2-yl)methyl]piperazine (LINS01007) as H4 R antagonist (pKi 6.2) and therefore the effects and pharmacological efficacy on a DSS-induced mice model of UC were assessed in this work. Experimental acute colitis was induced in male BALB/c mice (n = 5-10) by administering 3 % DSS in the drinking water for six days. The test compound LINS01007 was administered daily i...
April 22, 2024: International Immunopharmacology
https://read.qxmd.com/read/38652768/editorial-is-it-time-to-include-oral-vancomycin-in-therapeutic-guidelines-for-primary-sclerosing-cholangitis-associated-inflammatory-bowel-disease
#31
EDITORIAL
Ayesha Shah, Gerald Holtmann
No abstract text is available yet for this article.
May 2024: Alimentary Pharmacology & Therapeutics
https://read.qxmd.com/read/38652304/interactions-between-folate-metabolism-related-nutrients-and-polymorphisms-on-colorectal-cancer-risk-a-case-control-study-in-the-basque-country
#32
JOURNAL ARTICLE
Sara Corchero-Palacios, Iker Alegria-Lertxundi, Marian M de Pancorbo, Marta Arroyo-Izaga
Folate-mediated one-carbon metabolism (FOCM) plays an important role in colorectal carcinogenesis. Previous studies have assessed the role of folate-mediated one-carbon metabolism (FOCM)-related gene-diet interaction in the aetiology of colorectal cancer (CRC), however, the results remained inconclusive. Thus, this study aimed to investigate dietary factors and genetic variants related to FOCM, as well as potential nutrient-gene and nutrient-lifestyle interactions, on CRC risk. This observational study included 229 patients diagnosed with CRC and 229 age- and sex-matched subjects as controls from a population-based bowel cancer screening program...
April 23, 2024: European Journal of Nutrition
https://read.qxmd.com/read/38652257/mesenteric-sparing-approach-for-advanced-nodal-extent-in-small-intestinal-neuroendocrine-tumors-is-there-a-limit-to-the-vascular-resection-in-order-to-avoid-creating-a-short-small-bowel-syndrome-an-anatomic-research-study
#33
JOURNAL ARTICLE
Paul Bufacchi, Mathys Gomes-Jorge, Thomas Walter, Gilles Poncet, Arnaud Pasquer
PURPOSE: By selectively perfusing the first three jejunal arteries (JA), we aim to assess the individual perfusion length of small bowel (SB) and its impact on nodal resection in stage III-up small-intestinal neuroendocrine tumors (SI-NET). METHODS: Our anatomical research protocol implies a midline laparotomy and three measures of the SB length. We then perform a classical anterior approach of the superior mesenteric vessels. We carry on with the complete dissection and checking of the superior mesenteric artery (SMA) in order to identify the first three JA...
April 23, 2024: Surgical and Radiologic Anatomy: SRA
https://read.qxmd.com/read/38651930/reduction-of-product-composition-variability-using-pooled-microbiome-ecosystem-therapy-and-consequence-in-two-infectious-murine-models
#34
JOURNAL ARTICLE
Julie Reygner, Johanne Delannoy, Marie-Thérèse Barba-Goudiaby, Cyrielle Gasc, Benoît Levast, Enora Gaschet, Laurent Ferraris, Stéphane Paul, Nathalie Kapel, Anne-Judith Waligora-Dupriet, Frederic Barbut, Muriel Thomas, Carole Schwintner, Bastien Laperrousaz, Nathalie Corvaïa
Growing evidence demonstrates the key role of the gut microbiota in human health and disease. The recent success of microbiotherapy products to treat recurrent Clostridioides difficile infection has shed light on its potential in conditions associated with gut dysbiosis, such as acute graft-versus-host disease, intestinal bowel diseases, neurodegenerative diseases, or even cancer. However, the difficulty in defining a "good" donor as well as the intrinsic variability of donor-derived products' taxonomic composition limits the translatability and reproducibility of these studies...
April 23, 2024: Applied and Environmental Microbiology
https://read.qxmd.com/read/38651786/sarm1-controls-the-myd88-mediated-inflammatory-responses-in-inflammatory-bowel-disease-via-the-regulation-of-traf3-recruitment
#35
JOURNAL ARTICLE
Huijuan Fan, Chun Song, Jingyu Zhang
BACKGROUND: Sterile alpha and TIR motif-containing 1 (Sarm1) is known as a negative regulator of inflammatory responses. However, its role in inflammatory bowel disease (IBD) is still unclear. OBJECTIVE: This study aimed to explore the function of Sarm1 in IBD and its underlying mechanisms. Sarm1 and tumor necrosis factor (TNF) receptor associated factor 3 (TRAF3) knockout (KO) micewere established. METHODS: The colitis was induced using dextran sulfate sodium (DSS)...
April 23, 2024: Immunological Investigations
https://read.qxmd.com/read/38651771/meta-analysis-persistence-of-advanced-therapies-in-the-treatment-of-inflammatory-bowel-disease
#36
REVIEW
Tsz Hong Yiu, Yanna Ko, Aviv Pudipeddi, Patrizia Natale, Rupert W Leong
BACKGROUND: The expanding options in advanced therapies for ulcerative colitis (UC) and Crohn's disease (CD) present challenges in treatment selection. Persistence analysis assesses drug durability in real-world settings, acting as a surrogate marker for medication efficacy and tolerance. Unlike traditional comparative studies, persistence analysis provides insights extending beyond the initial year of treatment. AIM: To provide real-world evidence on treatment effectiveness, tolerability and preferences of physicians and patients regarding various advanced therapies for IBD...
April 23, 2024: Alimentary Pharmacology & Therapeutics
https://read.qxmd.com/read/38651743/predictors-of-irritable-bowel-syndrome-like-symptoms-in-quiescent-inflammatory-bowel-disease
#37
JOURNAL ARTICLE
Mehwish Ahmed, Autumn Pu, Kara Jencks, Shrinivas Bishu, Peter Higgins, William D Chey, Krishna Rao, Allen Lee
BACKGROUND: Many patients with quiescent inflammatory bowel disease (IBD) suffer from irritable bowel syndrome (IBS)-like symptoms. Although these symptoms cause significant reductions in quality of life, evidence-based treatments are lacking as risk factors and pathophysiology of these symptoms are not clearly defined. We aimed to identify risk factors for development of IBS-like symptoms in IBD patients with quiescent disease. METHODS: We performed a single-center retrospective cohort study of adults with IBD from 2015 to 2021...
April 23, 2024: Neurogastroenterology and Motility: the Official Journal of the European Gastrointestinal Motility Society
https://read.qxmd.com/read/38651688/-prostate-cancer-from-the-patients-perspective
#38
JOURNAL ARTICLE
Kent Lewén, Calle Waller, Henrik Grönberg, Ola Bratt
Prostate cancer is the most common cancer among Swedish men. To get this diagnose is not only a threat to the men's lives but also to their quality of life because the treatment often affects sexuality, bladder function and bowel function. It is therefore particularly problematic that the rehabilitation of men after treatment for prostate cancer often does not reach the standards set out in the national guidelines. Despite the past years' promotion of standardized cancer care pathways to speed up the process of investigating and treating cancer, the lead times for men who are being investigated for a suspicion of prostate cancer, or are waiting for a planned prostate cancer treatment, are the longest in Swedish cancer care...
April 23, 2024: Läkartidningen
https://read.qxmd.com/read/38651614/risk-factors-for-surgery-in-stricturing-small-bowel-crohn-s-disease-a-retrospective-cohort-study-from-the-getaid-p%C3%A3-diatrique
#39
JOURNAL ARTICLE
Edouard Lacotte, Louis Boujonnier, Christine Martinez-Vinson, Jérôme Viala, Delphine Ley, Stéphanie Coopman, Héloïse Lerisson, Alain Dabadie, Clémentine Dumant-Forrest, Bénédicte Pigneur, Frank Ruemmele, Raphael Enaud, Aurélie Comte, Julie Rebeuh, Valérie Bertrand, Nicolas Caron, Anne Breton, Rémi Duclaux-Loras, Ioana Vasies, Claire Dupont-Lucas
OBJECTIVES: Previous studies have shown rates of surgical resection of up to 41% in stricturing pediatric Crohn's disease. In this retrospective multicenter study, our aims were to identify clinical risk factors and magnetic resonance enterography (MRE) features of small bowel strictures associated with surgery. METHODS: Pediatric patients with symptomatic stricturing small bowel CD (defined as obstructive symptoms or proximal dilatation on MRE) confirmed by MRE between 2010 and 2020 were recruited from 12 French tertiary hospitals...
April 23, 2024: Journal of Pediatric Gastroenterology and Nutrition
https://read.qxmd.com/read/38651546/risk-factors-for-inadequate-bowel-preparation-before-colonoscopy-a-meta-analysis
#40
REVIEW
Lina Feng, Jialun Guan, Ruonan Dong, Kai Zhao, Mingyu Zhang, Suhong Xia, Yu Zhang, Liping Chen, Fang Xiao, Jiazhi Liao
OBJECTIVE: This meta-analysis aimed to comprehensively explore the risk factors for inadequate bowel preparation (IBP). METHODS: We searched the Embase, PubMed, Web of Science, and The Cochrane Library databases up to August 24, 2023, to identify observational studies and randomized controlled trials (RCTs) that examined risk factors for IBP. A random effects model was used to pool the adjusted odds ratios and 95% confidence intervals. RESULTS: A total of 125 studies (91 observational studies, 34 RCTs) were included...
April 23, 2024: Journal of Evidence-based Medicine
keyword
keyword
164307
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.